AEMD Q1 2026 Earnings NarrowerthanExpected Loss Boosts Investor Sentiment DRMA Q1 2026 Earnings NarrowerthanExpected Loss Marks Progress for ClinicalStage Biotech OCCI Q1 2026 Earnings Significant EPS Miss Driven by Losses in Credit Portfolio GPGI Q1 2026 Earnings EPS Misses Estimates by Over 53 as Profitability Pressures Emerge VRME Q4 2025 Earnings EPS Misses Estimates Amidst Challenging Quarter Decoy Therapeutics DCOY Surges 1075 Is Momentum Building for the Biotech Stock Leapfrog Acquisition Warrants LFACW Hold Steady at 028 Amid Quiet Trading Beazer Homes BZH Edges Higher as Housing Sector Finds Footing Envista Holdings NVST Faces Modest Pressure Near Key Support Levels Live Oak Bancshares Inc Q1 2026 Earnings EPS Beats Estimates by 174 Amid Mixed Market Response